Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Zjukovskaja

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Multiple Sclerosis and Related Disorders|October 18, 2022
Biomarkers of demyelination and axonal damage are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosisChristina Zjukovskaja, Anders Larsson, Honar Cherif, et al.
Bone Marrow Transplantation|August 26, 2024
BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosisThomas Silfverberg, Christina Zjukovskaja, Yassine Noui, et al.
Brain Communications|February 9, 2023
Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosisJoachim Burman, Christina Zjukovskaja, Anders Svenningsson, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 13, 2023
CSF Concentrations of CXCL13 and sCD27 Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple SclerosisKatarina Lundblad, Christina Zjukovskaja, Anders Larsson, et al.
Multiple Sclerosis and Related Disorders|February 11, 2024
Cerebrospinal fluid mtDNA concentrations are increased in multiple sclerosis and were normalized after intervention with autologous hematopoietic stem cell transplantationIvan Pavlovic, Christina Zjukovskaja, Faisal Hayat Nazir, et al.
Molecular Brain|June 28, 2022
Distribution of five clinically important neuroglial proteins in the human brainKarl Sjölin, Kim Kultima, Anders Larsson, et al.
Journal of the Neurological Sciences|May 13, 2025
Climate change impacts the symptomology and healthcare of multiple sclerosis patients through fatigue and heat sensitivity - A systematic reviewShala-Ghaderi Berntsson, Jacques Reis, Christina Zjukovskaja, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 6, 2025
Factors associated with outcomes following autologous haematopoietic stem cell transplantation for multiple sclerosisYassine Noui, Christina Zjukovskaja, Thomas Silfverberg, et al.
Iscience|June 19, 2023
Disease phenotype prediction in multiple sclerosisStephanie Herman, Staffan Arvidsson McShane, Christina Zjukovskaja, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 4, 2022
Impact of previous disease-modifying treatment on safety and efficacy in patients with MS treated with AHSCTSilje Agnethe Stokke Kvistad, Joachim Burman, Anne Kristine Lehmann, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Multiple Sclerosis and Related Disorders|October 18, 2022
Biomarkers of demyelination and axonal damage are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosisChristina Zjukovskaja, Anders Larsson, Honar Cherif, et al.
Bone Marrow Transplantation|August 26, 2024
BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosisThomas Silfverberg, Christina Zjukovskaja, Yassine Noui, et al.
Brain Communications|February 9, 2023
Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosisJoachim Burman, Christina Zjukovskaja, Anders Svenningsson, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 13, 2023
CSF Concentrations of CXCL13 and sCD27 Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple SclerosisKatarina Lundblad, Christina Zjukovskaja, Anders Larsson, et al.
Multiple Sclerosis and Related Disorders|February 11, 2024
Cerebrospinal fluid mtDNA concentrations are increased in multiple sclerosis and were normalized after intervention with autologous hematopoietic stem cell transplantationIvan Pavlovic, Christina Zjukovskaja, Faisal Hayat Nazir, et al.
Molecular Brain|June 28, 2022
Distribution of five clinically important neuroglial proteins in the human brainKarl Sjölin, Kim Kultima, Anders Larsson, et al.
Journal of the Neurological Sciences|May 13, 2025
Climate change impacts the symptomology and healthcare of multiple sclerosis patients through fatigue and heat sensitivity - A systematic reviewShala-Ghaderi Berntsson, Jacques Reis, Christina Zjukovskaja, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 6, 2025
Factors associated with outcomes following autologous haematopoietic stem cell transplantation for multiple sclerosisYassine Noui, Christina Zjukovskaja, Thomas Silfverberg, et al.
Iscience|June 19, 2023
Disease phenotype prediction in multiple sclerosisStephanie Herman, Staffan Arvidsson McShane, Christina Zjukovskaja, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 4, 2022
Impact of previous disease-modifying treatment on safety and efficacy in patients with MS treated with AHSCTSilje Agnethe Stokke Kvistad, Joachim Burman, Anne Kristine Lehmann, et al.
Pageof 2